On World Earth Day, Bormioli Pharma announced that in 2021 the company had doubled the use of sustainable raw materials in production compared to 2020, a result that well positions the company to achieve the goal declared last year of using 50% sustainable raw materials in production by 2025.

"We believe that sustainability must be pursued through concrete and measurable actions" commented Andrea Lodetti, CEO of Bormioli Pharma. "The acceleration we gave in 2021 to achieve the target is a sign of this commitment, but also of the growing interest we are gathering from the pharmaceutical industry".

The use of recycled glass and plastic, and bio-based plastics reached 32%, compared to 16% in 2020.

The doubling of the share of sustainable raw materials was made possible by a substantial increase in the use of recycled glass, and a concurrent increase in products made from responsible plastics, first and foremost rPET.

Thanks to many years of experience in the field of sustainable materials, Bormioli Pharma can now offer three different product ranges with lower environmental impact.

In addition, Bormioli Pharma continues its constant research activities, such as its participation in Glass Futures, a project that aims to define new industrial standards for reducing emissions in glass manufacturing.

www.bormiolipharma.com

Image: Increased cullet content leads the way to Bormioli Pharma reaching 50% recycled content by 2025.